← Ozempic

What podcasts say about Ozempic

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Ozempic

6 statements · 5 positive · 1 negative

  1. Sean O'MaraNegativeOct 4, 2026· The Megyn Kelly Show

    Stopping Ozempic and GLP medications causes obesity, weight, and disease to return.

    “as soon as you stop taking it, every study shows that obesity returns, weight gain, disease gain”

    Listen at 4:18:55

    Open the episode · Get Healthy, with Gary Brecka, Andrew Huberman, and Sean O'Mara
  2. Chloe MelleyPositiveSep 8, 2026· Stock Movers

    Semaglutide patent expirations enable Sandoz to sell cheaper generic versions.

    “that's paving the way for generic drug companies like Sandoz to sell cheaper versions of this key ingredient”

    Listen at 3:16

    Open the episode · Novartis Slumps, Sandoz Gains, Computacenter Up
  3. Johann HariPositiveAug 14, 2026· Big Technology Podcast

    Ozempic reduced Hari’s intake and produced 42 pounds of first-year weight loss.

    “It's why I went from eating 3,200 calories a day to about 1,800. It's why I lost 42 pounds in the first year.”

    Listen at 17:01

    Open the episode · Best of Big Technology: How Ozempic Changes Our Bodies, Minds, and Economy — With Johann Hari
  4. Novo Nordisk's 7.2-milligram semaglutide matched tirzepatide's weight-loss efficacy in a trial.

    “We have done a trial called Step Up with semaglutide at 7.2 milligram that shows actually weight loss efficacy on par with trisepatide.”

    Listen at 13:57

    Open the episode · Mad Money w/ Jim Cramer 2/4/26
  5. High-dose semaglutide produces weight loss comparable to tirzepatide

    “Step Up with semaglutide at 7.2 milligram that shows actually weight loss efficacy on par with trisepatide.”

    Listen at 13:58

    Open the episode · Mad Money w/ Jim Cramer 2/4/26
  6. Semaglutide provides cardiovascular, liver, and kidney protection.

    “semaglutide gives you cardio protection, liver protection, kidney protection”

    Listen at 14:27

    Open the episode · Mad Money w/ Jim Cramer 2/4/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.